Clinical Trials and Research1 min read
Liberia: Screening and Early Intervention for Sickle Cell Disease Ultimately Save Countries Money - Dr. Maureen Achebe
About this article
- Published
- Further reading
- Read More(opens in a new tab)

Dr. Maureen M. Achebe is Clinical Director of Hematology, Brigham and Women's Hospital, Boston, Massachusetts. She is an Associate Professor of Medicine and Global Health Equity at Harvard Medical School (HMS). Her area of excellence is Clinical Expertise and Innovation centres on the care of patients with haematologic conditions, sickle cell disease and iron deficiency, in particular and improvement in health equity for instance in individuals with a Duffy-null associated neutrophil count (DANC).
In this interview, she talks about the continental plan for sickle cell disease, as well as the benefits of newborn screening.